ABT:NYE-Abbott Laboratories (USD)

COMMON STOCK | Medical Devices | NYE

Last Closing Price

USD 105.00

Change

-0.39 (-0.37)%

Market Cap

USD 183.75B

Volume

4.83M

Avg Analyst Target

USD 120.71 (+14.96%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ABT Stock Forecast & Price:
Based on the Abbott Laboratories stock forecasts from 16 analysts, the average analyst target price for Abbott Laboratories is USD 120.71 over the next 12 months. Abbott Laboratories’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Abbott Laboratories is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Abbott Laboratories’s stock price was USD 105.00. Abbott Laboratories’s stock price has changed by +0.12% over the past week, +5.54% over the past month and -17.99% over the last year.

About Abbott Laboratories (ABT:NYE)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pha ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-11-29 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MDT Medtronic PLC

+0.35 (+0.46%)

USD105.24B 24.57 13.43
SYK Stryker Corporation

-0.07 (-0.03%)

USD88.08B 36.20 25.82
BSX Boston Scientific Corp

+0.71 (+1.62%)

USD63.24B 107.68 28.71
EW Edwards Lifesciences Corp

-0.93 (-1.23%)

USD47.21B 32.77 23.36
ZBH Zimmer Biomet Holdings Inc

+1.33 (+1.13%)

USD24.88B 76.99 19.48
STE STERIS plc

+0.15 (+0.08%)

USD18.03B 47.27 27.06
PHG Koninklijke Philips NV ADR

+0.15 (+1.04%)

USD13.08B 33.57 -14.09
BIO Bio-Rad Laboratories Inc

+1.14 (+0.29%)

USD11.95B 2.84 -1.50
BIO-B Bio-Rad Laboratories Inc

N/A

USD11.91B 3.59 -1.50
SNN Smith & Nephew SNATS Inc

+0.01 (+0.04%)

USD11.66B 23.70 11.35

ETFs Containing ABT

Symbol Name Weight Mer Price(Change) Market Cap
BTAL AGFiQ U.S. Market Neutral.. 0.00 % 1.54 %

N/A

USD0.36B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-0.59 (-1.07%)

USD0.74B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.15 %

-5.75 (-0.66%)

USD1.69B
ISDU:LSE iShares MSCI USA Islamic .. 0.00 % 0.60 %

-0.49 (-0.85%)

USD0.18B
ISDW:LSE iShares MSCI World Islami.. 0.00 % 0.60 %

-0.26 (-0.65%)

USD0.39B
ISUS:LSE iShares MSCI USA Islamic .. 0.00 % 0.60 %

-24.50 (-0.51%)

USD0.17B
ISWD:LSE iShares MSCI World Islami.. 0.00 % 0.60 %

-9.00 (-0.27%)

USD0.39B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.15 %

-0.10 (-0.96%)

USD2.90B
OPEN:LSE iShares Thomson Reuters I.. 0.00 % 0.25 %

-0.04 (-0.55%)

USD0.06B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

-0.45 (-1.10%)

USD0.44B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.30 %

-0.56 (-0.99%)

USD0.47B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.25 %

-0.48 (-0.98%)

USD1.74B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-29.00 (-0.64%)

USD0.78B
OPEN:F iShares VI Public Limited.. 0.00 % 0.25 %

+0.02 (+0.36%)

USD0.06B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.40 %

-1.75 (-0.28%)

USD1.25B
QDVG:F iShares V Public Limited .. 0.00 % 0.15 %

-0.01 (-0.08%)

USD2.09B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.25 %

+0.05 (+0.10%)

USD1.74B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

+0.06 (+0.15%)

USD0.44B
QDVG:XETRA iShares S&P 500 USD Healt.. 0.00 % 0.15 %

-0.07 (-0.67%)

USD2.05B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.25 %

-0.23 (-0.49%)

USD1.74B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.12 %

-0.35 (-0.66%)

USD0.74B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.15 %

-0.26 (-0.67%)

USD0.44B
HIG-U:CA Brompton Global Healthcar.. 0.00 % 0.75 %

N/A

USD0.05B
LONG:CA CI Global Longevity Econo.. 0.00 % 0.96 %

N/A

USD0.06B
ANEW ProShares MSCI Transforma.. 0.00 % 0.45 %

-0.11 (-0.36%)

USD0.02B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 1.00 %

-0.04 (-0.55%)

USD0.40B
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

-0.05 (-0.56%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.40 %

-0.06 (-0.83%)

USD1.25B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

USD0.05B
CURE Direxion Daily Healthcare.. 0.00 % 0.97 %

-1.02 (-0.88%)

USD0.20B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-0.49 (-0.52%)

USD0.09B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

-0.22 (-0.34%)

USD3.04B
FTCS First Trust Capital Stren.. 0.00 % 0.55 %

-0.02 (-0.03%)

USD8.90B
FUD:CA First Trust AlphaDEX US D.. 0.00 % 0.70 %

N/A

USD0.01B
IHI iShares U.S. Medical Devi.. 0.00 % 0.39 %

N/A

USD6.32B
IXJ iShares Global Healthcare.. 0.00 % 0.40 %

-0.18 (-0.21%)

USD3.76B
IYH iShares U.S. Healthcare E.. 0.00 % 0.39 %

-0.79 (-0.28%)

USD3.35B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

N/A

USD0.02B
MGV Vanguard Mega Cap Value I.. 0.00 % 0.06 %

+0.30 (+0.29%)

USD5.79B
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.04 (+0.05%)

USD0.33B
QDEF FlexShares Quality Divide.. 0.00 % 0.37 %

-0.02 (-0.04%)

USD0.35B
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.05 (+0.42%)

USD1.55M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.05 (+0.42%)

USD1.55M
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-0.59 (-0.24%)

USD17.26B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

-0.07 (-0.81%)

N/A
VIG Vanguard Dividend Appreci.. 0.00 % 0.08 %

-0.34 (-0.22%)

USD74.70B
VTV Vanguard Value Index Fund.. 0.00 % 0.04 %

+0.45 (+0.31%)

USD149.28B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.29 (-0.43%)

USD0.57B
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

-0.01 (-0.01%)

USD0.40B
XLV Health Care Select Sector.. 0.00 % 0.10 %

-0.34 (-0.25%)

USD39.84B
HHL:CA Healthcare Leaders Income.. 0.00 % 0.99 %

-0.07 (-0.84%)

USD0.33B
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.84 %

N/A

USD0.02B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

-0.16 (-0.72%)

USD0.01B
ACT Enact Holdings Inc 0.00 % 0.99 %

-0.02 (-0.08%)

USD3.99B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

+0.03 (+0.25%)

USD0.08B
RWDC Direxion MSCI Defensives .. 0.00 % 0.46 %

N/A

USD7.11M
GDNA Goldman Sachs Human Evolu.. 0.00 % 0.50 %

N/A

USD0.06B
FUD-A:CA First Trust Value Line Di.. 0.00 % 0.70 %

N/A

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -25.39% 58% F 31% F
Dividend Return 1.34% 56% F 28% F
Total Return -24.06% 61% D- 29% F
Trailing 12 Months  
Capital Gain -16.51% 64% D 45% F
Dividend Return 1.49% 56% F 27% F
Total Return -15.02% 67% D+ 42% F
Trailing 5 Years  
Capital Gain 86.27% 76% C 89% B+
Dividend Return 13.34% 88% B+ 54% F
Total Return 99.61% 94% A 89% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.41% 70% C- 84% B
Dividend Return 1.72% 67% D+ 42% F
Total Return 19.14% 73% C 83% B
Risk Return Profile  
Volatility (Standard Deviation) 16.97% 91% A- 65% D
Risk Adjusted Return 112.78% 97% A+ 99% A+
Market Capitalization 183.75B 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.79 79% C+ 28% F
Price/Book Ratio 5.23 24% F 14% F
Price / Cash Flow Ratio 17.45 36% F 21% F
EV/EBITDA 16.38 36% F 20% F
Management Effectiveness  
Return on Equity 22.37% 94% A 77% C+
Return on Invested Capital 13.83% 91% A- 78% C+
Return on Assets 8.82% 97% A+ 86% B
Debt to Equity Ratio 48.31% 42% F 61% D-
Technical Ratios  
Dividend Yield 1.76% 56% F 27% F
Short Ratio 2.16 70% C- 50% F
Short Percent 0.92% 81% B- 77% C+
Beta 0.69 84% B 75% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.